期刊文献+

阿利吉仑对急性心肌梗死大鼠心肌组织重构的影响 被引量:7

Effects of Aliskiren on Ventricular Remodeling After Acute Myocardial Infarction
暂未订购
导出
摘要 目的探讨阿利吉仑对大鼠心肌梗死后左室重构的影响及作用机制。方法 60只Wistar大鼠随机分为假手术组、模型对照组、培哚普利组和阿利吉仑组,每组15只。除假手术组外,其他3组均制作心肌梗死模型。培哚普利组和阿利吉仑组制作心肌梗死模型后分别给予培哚普利和阿利吉仑共8周。酶联免疫吸附测定(ELISA)检测血清中高敏C-反应蛋白(hs-CRP),免疫组织化学方法检测基质金属蛋白酶(MMP)-2、MMP-9、金属蛋白酶抑制因子(TIMP)-1和转化生长因子-β(TGF-β)的表达。逆转录聚合酶链反应(RT-PCR)检测心肌组织MMP-2、MMP-9、TIMP-1、TGF-β、CollagenⅠ和ⅢmRNA的表达。Western blotting检测心肌组织MMP-2、MMP-9、TIMP-1、TGF-β蛋白的表达。结果培哚普利组和阿利吉仑组血清hs-CRP明显低于模型对照组(P<0.05)。培哚普利组和阿利吉仑组MMP-2、MMP-9、TGF-β、CollagenⅠ和ⅢmRNA和蛋白的表达明显低于模型对照组(P<0.05),TIMP-1 mRNA的水平则高于模型模型对照组(P<0.05)。结论阿利吉仑通过下调MMP-2、MMP-9、TGF-β、CollagenⅠ和Ⅲ和hs-CRP表达、上调TIMP-1表达发挥作用。阿利吉仑和培哚普利在减轻大鼠心肌梗死后左室重构无明显差别。 Objective To investigate the effects of aliskiren on ventricular remodeling in rats with acute myocardialinfarction (AMI) and the related mechanism. Methods Sixty male Wistar rats were randomly assigned into four groups (n =15):sham group, control group, perindopril group and aliskiren group. After ligation of the anterior descending coronary artery,the rats in perindopril group and aliskiren group were given perindopril or aliskiren for 8 weeks, respectively. The concentration of hs-CRP in serum was assayed by ELISA. The expression of MMP-2, MMP-9, TIMP-1 and TGF-β was detected by immune-histochemistry. The mRNA expression of MMP-2, MMP-9, TIMP-1, TGF-β, Collagen Ⅰand Ⅲ was determined by RT-PCR.Protein expression of MMP-2, MMP-9, TIMP-1 and TGF-β was determined by Western blotting. Results The concentration ofhs-CRP was significantly lower in perindopril group and aliskiren group than in the control group ( P〈0. 05). The mRNA andprotein expression of MMP-2, MMP-9, TGF-β, Collagen Ⅰ and Ⅲ were significantly down-regulated in perindopril group andaliskiren group as compared to the sham group (P〈0. 05). Meanwhile, the mRNA and protein expression levels of TIMP-1 weresignificantly up-regulated in perindopril group and aliskiren group as compared to those in sham operated group ( P〈0. 05). Conclusion Aliskiren can downregulate the expression of MMP-2, MMP-9, TGF-β, Collagen Ⅰand Ⅲ and hs-CRP,upregulate TIMP-1. There is no significant difference between perindopril and aliskiren in ventricular remodeling in rats with AMI.
出处 《医药导报》 CAS 北大核心 2014年第2期167-172,共6页 Herald of Medicine
关键词 阿利吉仑 心肌梗死 急性 左室重构 Aliskiren Myocardial infarction, acute Ventricular remodeling
  • 相关文献

参考文献17

  • 1HIROTA H,CHEN J,BETZ U A,et al. Loss of a gp130cardiac muscle cell survival pathway is a critical event inthe onset of heart failure during biomechanical stress[J].Cell,1999,97(2):189-198.
  • 2IKEUCHI M,TSUTSUI H,SHIOMI T,et al. Inhibition ofTGF-beta signaling exacerbates early cardiac dysfunctionbut prevents late remodeling after infarction[J]. CardiovascRes,2004,64(3):526-535.
  • 3刘海珍,林琍,宗文霞.瑞舒伐他汀辅助治疗2型糖尿病并发心力衰竭58例[J].医药导报,2012,31(6):724-727. 被引量:1
  • 4骆高江,姜昌浩,陈智理,龚心琰.瑞舒伐他汀对慢性心力衰竭患者细胞因子及心功能的影响[J].医药导报,2013,32(1):44-47. 被引量:39
  • 5SADEK M M,HADDAD T,HADDAD H. The role of statinsin chronic heart failure[J]. Curr Opin Cardiol,2009,24(2):167-171.
  • 6RICCIONI G. Aliskiren in the treatment of hypertension andorgan damage[J]. Cardiovasc Ther,2011,29(-):77-87.
  • 7SACKNER-BERNSTEIN J D. The myocardial matrix and thedevelopment and progression of ventricular remodeling[J].Curr Cardiol Rep,2000,2(2):112-119.
  • 8LEE R T,LAMMERDING J. Signaling pathways that influ-ence extracellular remodeling[J]. J Card Fail,2002,8:339-343.
  • 9IKEUCHI M,TSUTSUI H,SHIOMI T,et al. Inhibition ofTGF-beta signaling exacerbates early cardiac dysfunctionbut prevents late remodeling after infarction[J]. CardiovascRes,2004,64(3):526-535.
  • 10BUJAK M,NIKOLAOS G F. The role of TGF-茁signaling inmyocardial infarction and cardiac remodeling [ J ].Cardiovascular Res,2007,74(2):184-195.

二级参考文献25

  • 1汪明灯,高修仁.炎症细胞因子与慢性心力衰竭[J].新医学,2006,37(3):200-202. 被引量:34
  • 2渠莉,王津文,于飞.他汀类药物的非调脂机制研究进展[J].中国医药,2006,1(6):379-381. 被引量:23
  • 3美国糖尿病学会2007版糖尿病诊疗标准[J].中国糖尿病杂志,2007,15(2):129-130. 被引量:113
  • 4吴波,张书富,陈德,马瑾,周依蒙,华尔铨.脑钠肽与高血压左室重塑、左室功能的关系[J].临床心血管病杂志,2007,23(7):510-512. 被引量:10
  • 5CAI L, KANG Y J. Cell death and diabetic cardiomyopathy [ J ]. Cardiovasc Toxicol, 2003,3 ( 3 ) :219-228.
  • 6RAY J G, GONG Y, SYKORA K, et al. Statin use and sur- vival outcomes in elderly patients with heart failure [ J ]. Arch Intern Med,2005,165 ( 1 ) :62-67.
  • 7SEMENOVA A E, SERGIENKO I V, MASENKO V P,et al. The influnce of rosuvastatin therapy and percutaneous coronary intervention on angiogenic growth factors in coronary artery disease patients [ J ]. Acta Cardiol, 2009,64 ( 3 ) :405-409.
  • 8RIDKER P M, DANIELSON E,FONSECA F A, et al. Rosu- vastatin to prevent vascular events in men and women with elevated C-reactive protein [ J ]. N Engl Med, 2008,359 ( 2 ) : 2195 -2207.
  • 9KJEKSHUS J, APETREI E, CORONA G, et al. Rosuvastatin in older patients with systolic heart failure [ J ]. N Engl J Med, 2007,357 ( 22 ) :2248-2256.
  • 10LEE E, RYAN S, BIRMINGHAM B, et al. Rosuvastatin ph- armacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment [ J ]. Clin Pharmacol Ther,2005,78 (4) :330-341.

共引文献38

同被引文献66

  • 1陈懿,徐世鄂.瑞舒伐他汀和阿托伐他汀对冠心病患者的调脂作用和安全性比较[J].中国老年学杂志,2014,34(9):2389-2390. 被引量:94
  • 2Sun Y. Intracardiac renin-angiotensin system and myocardial repair/remodeling following infarction [ J ]. J Mol Cell Cardi- ol,2010,48 (3) :483-489.
  • 3Mehta PK, Griendling KK. Angiotensin Ⅱ cell signaling:physi- ological and pathological effects in the cardiovascular system [ J]. Am J Physiol Cell Physiol,2007,292 ( 1 ) :C82-C97.
  • 4Susic D, Varagic J, Frohlich ED. Cardiovascular effects of inhi- bition of ren in-ang iotens in-aldosteron e system components in hypertensive rats given salt excess [ J ]. Am J Physiol Heart Circ Physio1,2010,298 (4) : 1177-1181.
  • 5Higashikuni Y, Takaoka M, Iwata H, et al. Aliskiren in combi- nation with valsartan exerts synergistic protective effects a- gainst ventricular remodeling after myocardial infarctio-n in mice[J]. Hypertension Research ,2012,35 ( 1 ) :62-69.
  • 6Yamamoto E, Kataoka K, Dong YF, et al. Aliskiren enhances the protective effects of valsartan against cardiovascular and renal Injury in endothelial nitric oxide synth-ase in deficient mice [ J ]. Hypertension,2009,54 ( 3 ) :633 -638.
  • 7Wang T, Wu DQ, Jiang XZ, et al. Novel thermosensitive hy- droGel injection inhibits post-infarct ventricle remodelling [J]. Eur J Heart Fail,2009,11 (1) :14-19.
  • 8Mahon NG, O'rorke C, Codd MB, et al. Hospitial mortality of acute myocardial infarction in the thrombolytic era[J]. Heart, 1999,81 (5) :478-482.
  • 9Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Di- agnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: devel- oped in collaboration with the International Society for Heart and Lung Transplantation [ J ]. Circulation, 2009,119 : e391- e479.
  • 10Bujak M,Frangogiannis NG. The role of TGF-I3 signaling in myocardial infarction and cardiac remodeling [ J ]. Cardiovasc Res,2007,74(2) :184-195.

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部